Cardiology trainee. Love sun, food and swimming 🏊♀️
Joined June 2009
- Tweets1.6K
- Following1.3K
- Followers624
- Likes2K
Vasiliki Tsampasian retweeted
Our work showed that climbing stairs is pretty good! Associated with a 39% cardiovascular death reduction and 24% overall mortality.
Thankful to @SophiePaddock @RathnaVeerni @CardioShades @justvick Emily and James!
link.springer.com/article/10…
@SpringerNature
CHOOSE STAIRS!
Vasiliki Tsampasian retweeted
📊 From the TriNetX global cohort (381K adults):
💊 Tirzepatide users showed:
•🔻 47% lower HF risk
•🔻 69% lower mortality
•🔻 54% fewer MACE
📄 Strong evidence for HF prevention in obesity.
🔗 tinyurl.com/4296nt83
Vasiliki Tsampasian retweeted
📢 Join us for another edition of the Journal Club in collaboration with EACVI!
⏳ 27 th of November 2025 17:00 CET
🎯 We'll be discussing
Socio-economic status, cardiovascular risk factors, and coronary atherosclerosis: a SCOT-HEART trial analysis, Jonathan R Weir-McCall et al. EJPC (March 2025)
together with Professor Mark Dweck and Doctor Edoardo Conte
Registration is open to everyone!
esc365.escardio.org/event/21…
Vasiliki Tsampasian retweeted
New in #EJPC: “Therapies leading to coronary atherosclerosis plaque regression” a joint scientific statement by #EAPC, #EACVI, and ESC WGs on Atherosclerosis&Pharmacotherapy.
🧬 Part 1 dives into atherosclerosis pathophysiology and imaging evaluation.
🔗 tinyurl.com/6rtrrtfs
Vasiliki Tsampasian retweeted
📢 New in #EJPC: “Differences in long-term impact of traditional risk factors for atherosclerosis on different arterial territories” insights from over 20 years of follow-up in the EPIC-Norfolk study
ow.ly/sL1E50XiX1O
@EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @justvick
Vasiliki Tsampasian retweeted
The present issue of the #EJPC is focused on the interplay between #pulmonary conditions and #cardiovascular consequences, and how to prevent them.
🔗academic.oup.com/eurjpc/issu…
Vasiliki Tsampasian retweeted
New data from >4 million adults in Japan show that while sleep apnoea syndrome (SAS) is less common in women, 💤 it confers a higher cardiovascular risk in women than in men.
Sex-specific strategies are needed for early detection and prevention.
tinyurl.com/4ejk33vn
Vasiliki Tsampasian retweeted
“What gets us into trouble is not what we don't know. It's what we know for sure that just ain't so”.
Don’t miss this must-read #EJPC editorial on rethinking the #obesityparadigm.
➡️Not all extra weight tells the same story.
In patients with STEMI, overweight & mild obesity showed lower mortality than normal weight, while only severe obesity was associated with risk.
➡️ Body weight impact is context-dependent.
academic.oup.com/eurjpc/adva…
Vasiliki Tsampasian retweeted
Daily flavan-3-ol intake (tea 🍵, cocoa 🍫, apples 🍎, grapes 🍇)
📉 lowers BP especially when elevated
💪 improves vascular function
🩺 A promising ally in CV prevention
tinyurl.com/y9e5zxpj
Vasiliki Tsampasian retweeted
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association. Read more in #EHJ 👉 ow.ly/uisk50Xe3mR
@RoccoMontone @ehj_ed #amyloidosis
Vasiliki Tsampasian retweeted
🔍How does your BP history shape your heart?
✅10-yr cumulative SBP→ ↑LV mass, ↓myocardial strain
✅ Long-term BP matters even without HT
✅ Impaired function & fibrosis risk ↑ independently of today's BP
🧠 Time-integrated BP=a key CV risk marker
🔗 shorturl.at/88kDc
Vasiliki Tsampasian retweeted
Looking forward to welcoming you in April at #ESCPrev26 💚
Step into the heart of #cvprev by registering early for the best savings, and submit your abstract by 20 Nov and clinical case by 27 Nov.
🔗Submit: escardio.org/Congresses-Even…
🔗Register: escardio.org/Congresses-Even…
@RitaPintoUL @SMosteoru #EAPC_ESC
Vasiliki Tsampasian retweeted
Join us in Ljubljana, we are preparing a memorable and packed #ESCPrev26 in the beautiful capital of 🇸🇮 #cvprev #cardiotwitter @justvick @PeroneFrancesco @EJPCEiC @ESC_Journals @Ajar_kocak @DrMarthaGulati @unilj @SMosteoru
Looking forward to welcoming you in April at #ESCPrev26 💚
Step into the heart of #cvprev by registering early for the best savings, and submit your abstract by 20 Nov and clinical case by 27 Nov.
🔗Submit: escardio.org/Congresses-Even…
🔗Register: escardio.org/Congresses-Even…
@RitaPintoUL @SMosteoru #EAPC_ESC
Vasiliki Tsampasian retweeted
Sex-specific associations between blood pressure in early midlife and arterial stiffness 27 years later: the Hordaland Health Study” published in #EJPC highlighting how midlife BP can shape vascular health decades down the line ow.ly/a4vK50XeKP9
@EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @justvick
Vasiliki Tsampasian retweeted
❤️ Can a breath test predict your heart risk?
An increased expiratory CO level on admission flagged:
❗ 3x higher 1-year mortality
❗ 6x ↑ risk of in-hospital MAEs
❗ A top-ranked predictor via machine learning
⛔️ CO: a silent signal—beyond smoking
shorturl.at/JC3YG
Vasiliki Tsampasian retweeted
⬆️Lp(a) levels are independently associated with subclinical coronary atherosclerosis in ageing endurance athletes and healthy controls even with low conventional CV risk.
👉 Highlights the value of Lp(a) for risk stratification in low-risk populations.
tinyurl.com/36yrv7tj
Vasiliki Tsampasian retweeted
🩺💻 A #telemedicine-based lipid-lowering strategy helped 82.6% of post-ACS patients reach LDL-c targets (<55 mg/dL) in just 3.2 months with improved #lipidcontrol and reduced #cardiovascular mortality.
🔗 tinyurl.com/kew86u62
Vasiliki Tsampasian retweeted
Super presentation on TV and the R Heart by @denisamuraru at @BSEcho .
Valuable insights on eRVEF & also which patients with moderate TR to refer to Heart Valve Centres @BSE_President @dr_benoy_n_shah @justvick @AVamvakidou @melanieackrill #bsecho2025
Vasiliki Tsampasian retweeted
💥 The “Global Leadership Initiative on Sarcopenia (GLIS)” model redefines sarcopenia not just by muscle mass or strength, but by clinical outcomes.
🏥 In 891 older HF patients, GLIS-defined sarcopenia=3.4×⬆️ 2-year mortality.
🚨 Prognosis matters!
🔗 tinyurl.com/37h25pja
Vasiliki Tsampasian retweeted
Mitral annular dysjunction-associated fibrosis on #WhyCMR 🩻
Learn how to spot scar in this condition in this excellent paper published in @EHJIMPEiC 🤩
1/4 patients with MAD = basal inferolateral scar
@alessia_gimelli @VDelgadoGarcia @pabloplopez_
academic.oup.com/ehjimp/arti…
